Search

everythinglearnresearchcommunity

for

Search:↓

TFC-loaded microneedles effectively promote hair regrowth in androgenetic alopecia.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

PRP treatment helps hair growth and rebalances scalp bacteria in androgenetic alopecia patients.

Lifestyle drugs are mainly used by wealthy people in India but could spread to others, affecting society and youth.

Topical finasteride may better target hair follicles without significant benefits over oral form.

Female pattern hair loss does not significantly affect sexual dysfunction.

Low testosterone can cause a heart rhythm problem in men, but fixing it can prevent the issue.

PRP helps tissue repair but lacks standard preparation methods.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

PRP therapy shows promise for anti-aging but lacks consistent evidence and standardization.

Prunus africana bark has the highest antioxidant activity and phenolic content.

BMI is a simple, cost-effective tool for screening obesity and related diseases.

FMH foods may help manage post-acute COVID-19 symptoms safely and easily.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

Finasteride, dutasteride, and silodosin have the highest risk for causing sexual dysfunction.

Long COVID affects many survivors with ongoing symptoms, needing more research and care.

Dermatologists should address discrimination and consider ethnic and gender differences in treatments.

Peripheral treatments showed some improvement in sexual dysfunction, but central symptoms remain challenging.

Drug repositioning is a promising way to quickly develop new treatments, especially for rare diseases.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

New methods may speed up drug development for male subfertility.

Australia needs better dermatological guidelines for gender-diverse patients.

Finasteride is effective for hair regrowth, but some believe it may cause persistent symptoms due to psychological factors.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

More research is needed to understand how testosterone is maintained in adult males.